Back to search

University of Thessaly (UTH)

Σύγκριση επιπέδων τελομεράσης σε ασθενείς με λοίμωξη από τους ιούς ηπατίτιδας Β & C

Abstract

dc:description

Telomeres are the natural ends of chromosomes, where the “end replication problem” takes place. This problem leads to the loss of 20-200bp from each chromosome after each cell division. The role of telomerase, an RNA-dependent DNA polymerase is to maintain the ends of chromosomes, so telomere lengths are extended or maintained and replicative senescence is avoided. Telomerase consists of two essential components: one is the functional RNA component hTR) which serves as a template for telomeric DNA synthesis and the other is a catalytic protein (hTERT) with reverse transcriptase activity. While most normal human somatic cells exhibit no detectable telomerase activity, highly proliferative cells such as germline cells, trophoblasts, hematopoietic cells, endometrial cells, and up to 85-90% of cancer cells, including hepatocellular carcinoma. The transcriptional regulation of hTERT expression depends on transcriptional factors that bind to the hTERT promoter and also on epigenetic mechanisms. DNA promoter methylation is one of the main epigenetic mechanisms that controls hTERT expression, due to the large number of CpG sites that are found in the promoter, though the role of DNA methylathion in hTERT regulation has not been elucidated yet. Hepatocellular carcinoma (HCC) is one of the most common malignant tumours worldwide. The major clinical risk factor for HCC development is chronic viral hepatitis, since 70–90% of HCCs develop in a HBV or HCV-related cirrhotic liver. It has been thought that chronic viral hepatitis provides the mitogenic and mutagenic environment that can cause the malignant transformation of hepatocytes. This may result in genetic alterations, such as activation or inactivation of several genes. hTERT is one of the genes that could be used for the construction of the “molecular profile” of patients suffering from chronic viral hepatitis. The main research of this thesis was the correlation of hTERT expression in chronic viral hepatitis tissues with the expression in normal and HCC liver tissues and the investigation of a mechanism that regulates hTERT expression. Three groups of patients were used: patients with chronic HBV and HCV infections, patients without liver disease which consisted the control group of the study and patients with histologically proven HCC. DNA and RNA were isolated from peripheral blood mononuclear cells and liver tissue biopsies. TRAP assay was performed to measure telomerase activity and real time PCR was used to quantify hTERT expression. Moreover, real time PCR and sequencing was used to determine the methylation status of hTERT promoter, in order to address the main factor that regulates hTERT expression in hepatocytes. The expression of hTERT transcripts in peripheral blood mononuclear cells was found to be significantly lower in the HBV and HCV patients compared to healthy controls and was not associated with the type of viral infection, the clinical status of the patients, age, sex, or aminotransferase levels. The presence of low levels of hTERT mRNA suggest the involvement of the catalytic subunit of telomerase in the immunopathogenesis of chronic hepatitis B and C since the decreased levels of hTERT mRNA expression represent a sign of premature aging of the immune system. Telomerase activity and hTERT expression was found high in all liver tissues of patients with HCC, while all normal liver tissues showed no telomerase activity and hTERT expression. This shows that hTERT mRNA overexpression in human liver tissues might be one of the processes involved in the multistep carcinogenesis of the liver. Additionally, we determined telomerase activity in liver tissues from patients with chronic viral hepatitis and observed that 15.6% of the specimens had detectable, although significantly lower than that observed in HCC cases- telomerase activity. Moreover, liver tissues from patients with chronic hepatitis B and C exhibit hTERT mRNA expression, associated with longer disease duration. Taking into account the above mentioned it can be suggested that patients with chronic viral hepatitis that demonstrated significant telomerase activity and increased hTERT mRNA levels on their tissues would require a careful and close follow-up for the potential development of HCC. We found that hTERT promoter region was highly methylated in normal liver tissues while in chronic viral hepatitis and HCC tissues was not methylated and highly expressed. Methylathion of CpG sites in hTERT promoter inhibits transcription factors (such as c-myc protein) to bind to the promoter and enhance transcription. Furthermore we have shown that hTERT methylation status is a prognostic marker of hepatocellular carcinomas progression and survival rate. Patients with very low PMR (percent of methylated reference) values had worse prognosis than patients with high PMR values. The use of methylathion status of hTERT promoter as a prognostic marker in patients with chronic viral hepatitis requires longer follow-up and the assessment of more clinical data.

Degree

thesis:*
Grantor dc:publisher
University of Thessaly (UTH)
Year dc:date
2006

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Satra, Maria
  • Σάτρα, Μαρία

Subjects

dc:subject × 16

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/34144

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Satra, Maria; Σάτρα, Μαρία. Σύγκριση επιπέδων τελομεράσης σε ασθενείς με λοίμωξη από τους ιούς ηπατίτιδας Β & C. University of Thessaly (UTH), 2006. http://hdl.handle.net/10442/hedi/34144